Aurobindo Pharma has won two prestigious awards at the 6th Global Generics & Biosimilars Awards 2019 for ‘Company of the Year and Acquisition of the Year’.
The company has been recognized as the Company of the Year for its outstanding development, innovation and success over the past year. The Acquisition of the Year award was given to the company following its acquisition of Sandoz Inc., USA's dermatology and oral solids businesses in the United States.
Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.
